Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Cellectar Biosciences, Inc. - Common Stock (NQ:CLRB)

0.3608 -0.0473 (-11.59%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Cellectar Biosciences, Inc. - Common Stock

< Previous 1 2 3 Next >
The trading volume of these stocks is deviating from the norm in today's session.
Let's have a look at what is happening on the US markets on Thursday. Below you can find the stocks with an unusual volume in today's session. 
Via Chartmill
Which stocks are gapping on Thursday?
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Thursday. Let's explore the market movements and identify the stocks with significant gaps. 
Via Chartmill
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Stay updated with the stocks that are on the move in today's after-hours session.
As the regular session of the US market concludes on Wednesday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses. 
Via Chartmill
What's going on in today's session
Here are the top movers in Wednesday's session, showcasing the stocks with significant price changes. 
Via Chartmill
Curious about the most active stocks on Wednesday?
Stay updated with the latest market activity on Wednesday. Explore the most active stocks in today's session and stay informed about the stocks that are in the spotlight. 
Via Chartmill
Crude Oil Falls Over 1%; ISM Services PMI Tumbles In May
Via Benzinga
Exposures Fossil Fuels
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
What's Behind Cellectar Biosciences' Stock Surge? FDA Update Explained
Cellectar's Iopofosine I 131 earned FDA breakthrough therapy designation for relapsed Waldenstrom macroglobulinemia following strong trial data. 
Via Benzinga
Exposures Product Safety
Which stocks are experiencing notable movement on Wednesday?
Curious to know what's happening on the US markets in the middle of the day on Wednesday? Join us as we explore the top gainers and losers in today's session. 
Via Chartmill
US Stocks Higher; Dollar Tree Shares Plunge After Q1 Earnings
Via Benzinga
Wednesday's session: gap up and gap down stocks
In today's session, there are notable price gaps in the US markets on Wednesday. Take a closer look at the stocks that are gap up and gap down. 
Via Chartmill
Earnings Scheduled For May 13, 2025
Via Benzinga
Insights Ahead: Cellectar Biosciences's Quarterly Earnings
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Earnings Scheduled For March 13, 2025
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Crude Oil Jumps 2%; Macy's Lowers Earnings Forecast
Via Benzinga
Exposures Fossil Fuels
Cellectar Biosciences Stock Plunges As Cancer-Focused Cancer Firm Pursues Strategic Options
Due to FDA communications, Cellectar Biosciences will explore options for development of its cancer drug. Focus on isotopes for solid tumors. 
Via Benzinga
Exposures Product Safety
Nasdaq Surges Over 1%; US Inflation Rises In-Line With Expectations
Via Benzinga
Topics Economy
Exposures Interest Rates
Why Stitch Fix Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Earnings Scheduled For November 18, 2024
Via Benzinga
Gold Moves Higher; Coca-Cola Increases FY24 Forecast
Via Benzinga
Crude Oil Down 2%; GE Aerospace Earnings Top Views
Via Benzinga
Exposures Fossil Fuels
Cancer-Focused Cellectar Biosciences Stock Trades Lower Despite Meeting Goal In Blood Cancer Study
Cellectar Biosciences stock drops 19.2% following the release of CLOVER WaM study results. The pivotal study for iopofosine I 131 in relapsed/refractory Waldenstrom's macroglobulinemia showed an 80%... 
Via Benzinga
CLRB Stock Earnings: Cellectar Biosciences Misses EPS for Q1 2024
CLRB stock results show that Cellectar Biosciences missed analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
Why Comcast Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Hedgeye Warns That Reddit (RDDT) Stock Will Fall 50%
Reddit stock is a hot topic among traders on Wednesday after one analyst warns that RDDT could give up 50% of its gains. 
Via InvestorPlace
Why Is Gamida Cell (GMDA) Stock Down 82% Today?
Gamida Cell stock is falling on Wednesday with heavy trading of GMDA shares after the company announced plans to go private. 
Via InvestorPlace
CLRB Stock Earnings: Cellectar Biosciences Beats EPS for Q4 2023
CLRB stock results show that Cellectar Biosciences beat analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.